Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
FANCM protein truncating variants (PTVs) are emerging as risk factors for ER-negative and triple negative breast cancer. Here, we discuss evidence that greatest risk associates with PTVs, such as p.Arg658*, that extensively truncate the 2048 amino acid FANCM protein. Moreover, risks associated with...
Guardado en:
Autores principales: | Paolo Peterlongo, Gisella Figlioli, Andrew J. Deans, Fergus J. Couch |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/104eda8a91d541078387d85e7e6c593d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Triple-negative (ER, PgR, HER-2/neu) breast cancer in Indian women
por: Vinayak W Patil, et al.
Publicado: (2011) -
A triple negative breast cancer: what it is not!
por: Katakkar SB
Publicado: (2012) -
Triple negative breast cancer: an Indian perspective
por: Akhtar M, et al.
Publicado: (2015) -
Molecular heterogeneity in adjacent cells in triple-negative breast cancer
por: Huebschman ML, et al.
Publicado: (2015) -
RIPK1 is a negative mediator in Aquaporin 1-driven triple-negative breast carcinoma progression and metastasis
por: Zhuming Yin, et al.
Publicado: (2021)